재규어 헬스 (JAGX)

Feb 13, 2026

Is Jaguar Health Inc. stock a safe buy before earningsJuly 2025 Technicals & Trade Opportunity Analysis Reports - mfd.ru

Feb 13, 2026

Feb 13, 2026

Is Jaguar Health Inc. undervalued by DCF analysisQuarterly Risk Review & High Conviction Investment Ideas - mfd.ru

Feb 13, 2026

Feb 12, 2026

Is Jaguar Health Inc. stock showing strong momentum2025 Big Picture & Weekly High Return Stock Opportunities - mfd.ru

Feb 12, 2026

Feb 12, 2026

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY - TradingView

Feb 12, 2026

Feb 09, 2026

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million - Marco Eagle

Feb 09, 2026

Jan 31, 2026

Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts - The Marion Star

Jan 31, 2026

Jan 29, 2026

Should value investors consider Jaguar Health Inc.July 2025 Opening Moves & Weekly Breakout Watchlists - mfd.ru

Jan 29, 2026

Jan 28, 2026

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - hattiesburgamerican.com

Jan 28, 2026

Jan 27, 2026

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - The Asheville Citizen Times

Jan 27, 2026

Jan 26, 2026

Jaguar Health Executes Debt-Reducing Equity Warrant Transactions - TipRanks

Jan 26, 2026

Jan 26, 2026

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - citizen-times.com

Jan 26, 2026

Jan 23, 2026

Jaguar Health Signs Multiple Material Agreements - TradingView

Jan 23, 2026

Jan 22, 2026

Jaguar Health (JAGX) Advances Rare Disease Program with Focus on Crofelemer - GuruFocus

Jan 22, 2026

Jan 22, 2026

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi - Lansing State Journal

Jan 22, 2026

Jan 22, 2026

Jaguar trial cuts children’s IV support needs by up to 37% - Stock Titan

Jan 22, 2026

Jan 22, 2026

Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - barnstablepatriot.com

Jan 22, 2026

Jan 19, 2026

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs - Pueblo Chieftain

Jan 19, 2026

Jan 19, 2026

Earnings Report: Is Jaguar Health Inc a defensive stock2025 Valuation Update & Scalable Portfolio Growth Ideas - baoquankhu1.vn

Jan 19, 2026

Jan 18, 2026

Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication - dailycommercial.com

Jan 18, 2026

Jan 18, 2026

Recent Developments in Jaguar Health - StocksToTrade

Jan 18, 2026

Jan 18, 2026

Strategic Licensing Boosts Jaguar Health’s Market Momentum - timothysykes.com

Jan 18, 2026

Jan 17, 2026

Swing Trade: Is Jaguar Health Inc on track to beat earningsJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn

Jan 17, 2026

Jan 17, 2026

Jaguar Health Enters Exclusive Licensing Agreement Boosting Market Dynamics - timothysykes.com

Jan 17, 2026

Jan 16, 2026

The Surge In Jaguar Health Stock: What's Happening Now? - Sahm

Jan 16, 2026

Jan 16, 2026

Jaguar Health’s Licensing Deal Boosts Financial Prospects - StocksToTrade

Jan 16, 2026

Jan 16, 2026

Jaguar Health Soars Amid Licensing Deals and Study Breakthroughs - timothysykes.com

Jan 16, 2026

Jan 16, 2026

Jaguar Health Inc surges amid market gains - Intellectia AI

Jan 16, 2026